Multimodal clinical imaging to longitudinally assess a nanomedical anti-inflammatory treatment in experimental atherosclerosis.
Lobatto
Mark E
ME
Translational and Molecular Imaging Institute and Imaging Science Laboratories, Mount Sinai School of Medicine, One Gustave L Levy Place, New York, New York 10029, United States.
Fayad
Zahi A
ZA
Silvera
Stephane
S
Vucic
Esad
E
Calcagno
Claudia
C
Mani
Venkatesh
V
Dickson
Stephen D
SD
Nicolay
Klaas
K
Banciu
Manuela
M
Schiffelers
Raymond M
RM
Metselaar
Josbert M
JM
van Bloois
Louis
L
Wu
Hai-Shan
HS
Fallon
John T
JT
Rudd
James H
JH
Fuster
Valentin
V
Fisher
Edward A
EA
Storm
Gert
G
Mulder
Willem J M
WJ
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000188:drug therapy*; D004195:Disease Models, Animal; D016503:Drug Delivery Systems; D005938:Glucocorticoids / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008081:Liposomes / Q000737:chemistry; D008137:Longitudinal Studies; D008279:Magnetic Resonance Imaging; D008297:Male; D050997:Nanomedicine; D049268:Positron-Emission Tomography; D011817:Rabbits
D000894:Anti-Inflammatory Agents, Non-Steroidal; D005938:Glucocorticoids; D008081:Liposomes